GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (TSX:APLI) » Definitions » YoY EPS Growth

Appili Therapeutics (TSX:APLI) YoY EPS Growth : 0.00% (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Appili Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Appili Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2024 was 0.00%.

Appili Therapeutics's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was C$-0.01.

Appili Therapeutics YoY EPS Growth Historical Data

The historical data trend for Appili Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Appili Therapeutics YoY EPS Growth Chart

Appili Therapeutics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
YoY EPS Growth
Get a 7-Day Free Trial -24.03 -50.00 -58.33 78.95 62.50

Appili Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 95.00 50.00 - -

Appili Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Appili Therapeutics's YoY EPS Growth for the fiscal year that ended in Mar. 2024 is calculated as:

YoY EPS Growth (A: Mar. 2024 )
=(Earnings per Share (Diluted) (A: Mar. 2024 )-Earnings per Share (Diluted) (A: Mar. 2023 ))/ | Earnings per Share (Diluted) (A: Mar. 2023 ) |
=(-0.03--0.08)/ | -0.08 |
=62.50 %

Appili Therapeutics's YoY EPS Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EPS Growth (Q: Sep. 2024 )
=(Earnings per Share (Diluted) (Q: Sep. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(-0.01--0.01)/ | -0.01 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Appili Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Appili Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Appili Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Appili Therapeutics Inc (TSX:APLI) » Definitions » YoY EPS Growth
Comparable Companies
TSXV:RP XCNQ:MESC TSXV:IOT TSXV:RKV XCNQ:MBIO XCNQ:BRAX XCNQ:NOVA XCNQ:BIOV XCNQ:GLOW XCNQ:BETR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
APLIF:USA
Address
1344 Summer Street, Suite 21, Halifax, NS, CAN, B3H 0A8
Website
https://www.appilitherapeutics.com
Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes programs namely ATI-1701, ATI-1801.
Executives
Donald Cilla Director
The K2 Principal Fund L.p. 10% Security Holder

Appili Therapeutics Headlines

No Headlines